Search

Author/Creator Hang, Yaming

1. A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation. Issue 2 (12th June 2021)

Authors:
Ahamadi, Malidi; Mehrotra, Nitin; Hanan, Nathan; Lai Yee, Ka; Gheyas, Ferdous; Anton, Judith; Bani, Massimo; Boroojerdi, Babak; Smit, Hans; Weidemann, Jonas; Macha, Sreeraj; Thuillier, Vincent; Chen, Chao; Yang, Minhua; Williams‐Gray, Caroline H.; Stebbins, Glenn T.; Pagano, Gennaro; Hang, Yaming...
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 110:Issue 2(2021)
Page Start:
508
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Population PK–PD analyses of CD25 occupancy, CD56bright NK cell expansion, and regulatory T cell reduction by daclizumab HYP in subjects with multiple sclerosis. (3rd August 2016)

Authors:
Diao, Lei; Hang, Yaming; Othman, Ahmed A.; Mehta, Devangi; Amaravadi, Lakshmi; Nestorov, Ivan; Tran, Jonathan Q.
Journal:
British journal of clinical pharmacology
Issue:
Volume 82:Number 5(2016:Nov.)
Page Start:
1333
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗